Ocular Therapeutix Inc
- Stock Issuer and Owners
Ocular Therapeutix Inc |
Ticker | OCUL |
CIK # | 0001393434 |
CUSIP | 67576A100 |
Sector | Life Sciences - Pharmaceutical Preparations |
Address | 36 Crosby Drive Suite 101, Bedford, MA 01730 |
Source |
[EDGAR]
|
Form 13F Holdings |
Firm |
Period |
DFND |
Voting |
Shares |
Summer Road LLC |
[2023-03-31]
|
DFND |
6,122,089.0 |
6,122,089.0 |
Opaleye Management Inc |
[2023-03-31]
|
SOLE |
6,105,900.0 |
6,105,900.0 |
BlackRock Inc. |
[2023-03-31]
|
SOLE |
4,884,541.0 |
4,918,309.0 |
Vanguard Group Inc |
[2023-03-31]
|
SOLE |
0.0 |
3,895,751.0 |
Citadel Advisors LLC |
[2023-03-31]
|
DFND |
1,975,072.0 |
1,975,072.0 |
Deltec Asset Management LLC |
[2023-03-31]
|
SOLE |
1,913,612.0 |
1,913,612.0 |
State Street Corp |
[2023-03-31]
|
DFND |
1,413,595.0 |
1,492,959.0 |
Geode Capital Management LLC |
[2023-03-31]
|
DFND |
1,457,740.0 |
1,457,740.0 |
Morgan Stanley |
[2023-03-31]
|
DFND |
1,071,739.0 |
1,181,703.0 |
D. E. Shaw & Co., Inc. |
[2023-03-31]
|
DFND |
1,099,770.0 |
1,099,770.0 |
Millennium Management LLC |
[2023-03-31]
|
SOLE |
1,036,555.0 |
1,036,555.0 |
Susquehanna International Group LLP |
[2023-03-31]
|
DFND |
244,579.0 |
713,179.0 |
Northern Trust Corp |
[2023-03-31]
|
DFND |
31,768.0 |
657,097.0 |
Cetera Investment Advisers |
[2023-03-31]
|
SOLE |
0.0 |
601,150.0 |
Endurant Capital Management LP |
[2023-03-31]
|
SOLE |
512,744.0 |
512,744.0 |
UBS OConnor LLC |
[2023-03-31]
|
DFND |
363,286.0 |
363,286.0 |
Two Sigma Investments LP |
[2023-03-31]
|
SOLE |
323,424.0 |
323,424.0 |
Two Sigma Advisers LP |
[2023-03-31]
|
SOLE |
243,100.0 |
309,400.0 |
Wellington Management Group LLP |
[2023-03-31]
|
DFND |
0.0 |
307,108.0 |
Knoll Capital Management, LLC |
[2023-03-31]
|
SOLE |
295,800.0 |
295,800.0 |
Bank of New York Mellon Corp |
[2023-03-31]
|
DFND |
260,699.0 |
290,055.0 |
Barclays PLC |
[2023-03-31]
|
SOLE |
279,687.0 |
279,687.0 |
Banco Santander, S.A. |
[2023-03-31]
|
DFND |
267,889.0 |
267,889.0 |
Levin Capital Strategies LP |
[2023-03-31]
|
OTR |
0.0 |
207,624.0 |
Charles Schwab Investment Management Inc |
[2023-03-31]
|
SOLE |
206,249.0 |
206,249.0 |
Ikarian Capital LLC |
[2023-03-31]
|
SOLE |
200,000.0 |
200,000.0 |
Nottingham Advisors Inc |
[2023-03-31]
|
SOLE |
0.0 |
194,266.0 |
Nuveen Asset Management LLC |
[2023-03-31]
|
DFND |
193,033.0 |
193,033.0 |
Goldman Sachs Group Inc |
[2023-03-31]
|
DFND |
180,605.0 |
180,665.0 |
Royal Bank of Canada |
[2023-03-31]
|
DFND |
180,001.0 |
180,001.0 |
Prev | Page 1 | Next
|
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}
{"uid": 120617767, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
163734092